The “RNAi Therapeutics Market (2nd Edition), 2019 - 2030: Focus on siRNA, miRNA, shRNA and DNA” report features an extensive study of the current market landscape, offering...

Although vaccines were solely responsible for the global eradication of smallpox (1980) and polio (2015), several vaccine-preventable diseases, such as measles and mumps, are still a threat; COVID-19 has been recently added to the list

The ‘Prefilled Syringes Market (5th edition), 2019-2030’ report features an extensive study of the current market landscape of prefilled syringes

The ‘Elastomeric Closure Components Market for Vials, Cartridges and Syringes, 2019-2030: Focus on Caps, Needle Shields, Plungers, Stoppers, Seals, Tip Caps and Other Closures

The “Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020-2030” report features an extensive study on the current market landscape and future of companies offering services for peptides and macrocycle drug discovery operations.

The “China Biopharmaceutical Contract Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of biopharmaceuticals in China.

RNAi Therapeutics Market is projected to grow at an annualized rate of ~45%, till 2030

More than 200 preventive vaccines, developed by both industry and non-industry players, are being evaluated in clinical stages of development, claims Roots Analysis

More than 35 industry players claim to offer services for the identification, characterization and development of peptides and macrocycle-based pharmacological lead candidates, claims Roots Analysis

Currently, there are over 240 closures, fabricated using a variety of elastomeric materials, available for use in parenteral primary packaging containers; majority of these products are available in the ready-to-use format, claims Roots Analysis

Over 35 CMOs / CDMOs in China claim to offer a variety of services related to development and manufacturing of a wide range of biotherapeutic products, claims Roots Analysis

RNAi Therapeutics Market is estimated to be worth USD 9.2 billion in 2030, predicts Roots Analysis

The Global Preventive Vaccines Market is projected to be worth USD 94 billion, by 2030, growing at a CAGR of 10.7%, claims Roots Analysis

Roots Analysis has done a detailed study on Prefilled Syringes, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.

The Peptides and Macrocycle Drug Discovery Services Market is estimated to be worth USD 1.5 billion in 2030, predicts Roots Analysis

The Elastomeric Closures Market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis

The Chines Biopharmaceutical Contract Manufacturing Market is projected to grow at an annualized rate of ~13%, till 2030

The Global Preventive Vaccines Market is projected to be worth USD 94 billion by 2030, growing at a CAGR of 10.7%, claims Roots Analysis

The Prefilled Syringes Market is estimated to be worth over USD 2.5 billion in 2030, predicts Roots Analysis

The Peptides And Macrocycle Drug Discovery Services Market is projected to reach USD 1.5 Billion by 2030, growing at an annualized rate of 10.5%, claims Roots Analysis

The Elastomeric Closures Market is projected to reach USD 9.3 Billion by 2030, growing at an annualized rate of 6.7%, claims Roots Analysis

The Chinese Biopharmaceutical Contract Manufacturing Market is estimated to be worth USD 2.6 billion in 2030, predicts Roots Analysis

Next Generation Contact Lenses and Visual Prostheses Market, 2019-2030” report features an extensive study of the current market landscape

Medical Device CROs Market (2nd Edition), 2020-2030’ report features an extensive study of the current market landscape and future opportunities

Over 270 companies worldwide have the necessary expertise and authorization to offer contract manufacturing services for various types of medical devices, including therapeutic and diagnostic products

Autoinjectors Market (3rd Edition), 2020-2030’ report features an extensive study of the current market landscape, offering an informed

Antibody Drug Conjugates Market (5th Edition), 2019-2030’ report features an extensive study of the current market ...

Over 55 novel ophthalmic products are currently available / being developed for various therapeutic, diagnostic & monitoring and drug delivery applications; their growing popularity is evident across social media as well, claims Roots Analysis

Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclinical and clinical research-related services to medical device-focused business entities, claims Roots Analysis

Over 270 companies worldwide have the necessary expertise and authorization to offer contract manufacturing services for various types of medical devices

Currently, several companies claim to be engaged in the development / manufacturing of various types of autoinjectors, most of which are disposable systems that use prefilled syringes as primary drug containers, claims Roots Analysis

Presently, over 240 ADC therapy candidates are being evaluated in clinical / preclinical stages for treating a variety of solid tumors / hematologic cancers, claims Roots Analysis

The Next Generation Contact Lenses and Visual Prostheses Market is projected to grow at an annualized rate of 52%, till 2030

The Medical Device CRO Market is projected to grow at an annualized rate of 6.4%, till 2030

The Medical Device Contract Manufacturing Market is projected to grow at an annualized rate of 8%, till 2030

The Global Autoinjectors Market is projected to grow at an annualized rate of ~10% and be worth around USD 2.5 Billion, till 2030

Roots Analysis has done a detailed report on Antibody Drug Conjugates Market, covering various important aspects of the industry and identifying key future growth opportunities.

Next Generation Contact Lenses and Visual Prostheses Market is estimated to be worth USD 3.7 billion in 2030, predicts Roots Analysis

The Medical Device CRO Market is estimated to be worth USD 15.7 billion in 2030, predicts Roots Analysis

The Medical Device Contract Manufacturing Market is estimated to be worth USD 126 Billion in 2030, predicts Roots Analysis

The Global Autoinjectors Market is projected to grow at an annualized rate of over 10%, till 2030

Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community.

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices” report features an extensive study of the current market landscape

Global Handheld Ultrasound Imaging Devices Market, 2020-2030” report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of such compact diagnostic devices, over the next decade.

The first monoclonal antibody, Orthoclone OKT3®, was approved in 1986 by the FDA. Since then, a number of antibody therapeutics (more than 100) have been marketed for the treatment of patients suffering

The microbiome therapies pipeline features 260 drugs under evaluation across different phases of development; contract service providers have become an integral part of the supply chain owing to their technical expertise, claims Roots Analysis

More than 40 large volume wearable injectors are presently available / under development for the administration of drugs, beyond insulin, including 15+ drug-device combinations

Several players are currently engaged in the development / manufacturing over 100 point-of-care handheld ultrasound scanners that are being actively used for remote monitoring of patients by doctors / physicians

The “Gene Therapy Market (3rd Edition), 2019-2030” report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral therapies and genome editing therapies.